To investigate oncogenic genetic alterations in cervical cancer, Xiang et al. 64 examined the mutational status of 16 oncogenic genes, such as FGFR2 and FGFR3 as well as FGFR3-TACC3, FGFR1-TACC1 fusions in a cohort of 285 Chinese patients with resected cervical cancer. This evidence concerns the gene TACC3 and cervical carcinoma.